Dergiler / Marmara Medical Journal / 2026 / Volume: 4 Issue: 1

Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

Sayfa
—
Yayın Tarihi
1991-01-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

No serious adverse reactions attributable to the vaccine, were observed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults.
📊
Temel Bulgular & Veri:Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule.
💡
Sonuç & Katkı:No serious adverse reactions attributable to the vaccine, were observed.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Hepatitis B · prevention and control

Abstract

We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults. Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule. One month after the third dose, seroconversion rate was 100% and all subjects had antibodies to hepatitis B surface antigen tilers in excess of 10IU / L. No serious adverse reactions attributable to the vaccine, were observed.

🔖

Bu Makaleye Atıf Yap

Pamukçu, M., Mutlu, G., Yakupoğlu, G., Süleymanlar, G., Yeğin, 0. (1991). Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Medical Journal, Volume: 4 Issue: 1. https://ajindex.com/articles/1287705

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...